Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS
暂无分享，去创建一个
W. Wiedemeyer | B. Karlan | S. Orsulic | E. Spiteri | Qiang Wang | C. Walsh | R. Wiedemeyer | T. Mizuno | V. Funari | H. Agadjanian | Dong-Joo Cheon | P. Aspuria | L. Spurka | B. Taylor-Harding | Jenieke R. Allen | Danielle Greenberg